Trials / Conditions / Leukemia Relapse
Leukemia Relapse
4 registered clinical trials studyying Leukemia Relapse — 2 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | Study of Allo-QuadCAR01-T, an Allogeneic CAR-T Targeting CD19/CD20, in Patients With Relapsed or Refractory B- NCT07284433 | AvenCell Therapeutics, Inc. | Phase 1 / Phase 2 |
| Recruiting | Decitabine Plus mBU/CY for High Risk Acute Leukemia With MRD Pre-HSCT NCT03793517 | Peking University People's Hospital | Phase 2 / Phase 3 |
| Unknown | A Optimal Anti-Thymoglobuline (ATG) Dose Decrease cGVHD But Not Increase Leukemia Relapse for Haplo-HSCT NCT03190733 | Zhujiang Hospital | Phase 4 |
| Terminated | Identification of New Immune Factors Specific of Relapse in Childhood B Lineage Acute Lymphoblastic Leukemia NCT02618109 | University Hospital, Angers | Phase 4 |